In certain subtypes, particularly those with classical differentiation, overexpression of HNF4α supports tumor progression by promoting metabolic reprogramming—notably enhancing lipogenesis and glycolysis through the SREBP-1c and mTOR pathways. The gene discussed is HNF4A; the disease is neoplasm.